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Development of a Scalable Synthesis of 
HP-β-CD Pluronic Polyrotaxanes
Student researchers: Joseph L. Skulsky, Senior, 
and Elizabeth A. Slepko, Junior
Polyrotaxanes are polymers that have macrocycles threaded onto 
them, analogous to beads threaded onto a string. These materials 
are used for a variety of biomedical applications. The Thompson 
Group has been developing 2-hydroxypropyl-β-cyclodextrin 
(HP-β-CD) polyrotaxanes as therapeutics for the treatment of 
Niemann-Pick Type C (NPC) disease, a debilitating genetic 
disorder in which unesterifi ed cholesterol accumulates in the 
lysosomes of cells. Developing a scalable process is crucial for 
the advancement of these materials as NPC therapeutics. The goal 
of this project is to optimize a protocol for the synthesis of HP-
β-CD/Pluronic polyrotaxanes in order to develop a method that 
can be operated on the multi-gram scale to support preclinical 
studies. Each component of the protocol was screened to determine 
which combination led to the formation of polyrotaxanes with the 
highest yields and threading effi ciencies in the shortest amount 
of time. Threading effi ciency is a measure of how many HP-β-
CD molecules are threaded onto each polymer. Nuclear magnetic 
resonance (NMR) spectroscopy suggested that probe sonication 
and bath sonication are both necessary components of the optimal 
protocol. This indicates that suffi cient agitation of the reaction 
mixture is required to promote the non-covalent threading 
reaction. Furthermore, bath sonication for one hour, followed 
by stirring for two days, gave the highest threading effi ciency. 
The results of these studies have streamlined the existing protocol 
for HP-β-CD and Pluronic F127 and for HP-β-CD and Pluronic 
L81; however, additional studies are needed to reveal whether this 
protocol is robust enough for effi cient preparation of other HP-β-
CD/Pluronic polyrotaxane derivatives.
Research advisor David H. Thompson writes: “The students 
worked tirelessly in the David H. Thompson Lab in the Purdue 
Department of Chemistry to prepare a family of ’wheel-and-axle’ 
type of polymers known as polyrotaxanes. These compounds are 
of great interest because of their capacity to serve as cholesterol-
mobilizing molecules in Niemann-Pick Type C disease, as well 
as potentially acting as long circulating MRI agents for tumor 
detection. The students’ work has laid an important foundation for 
us to pursue these applications by working out the details of their 
effi cient synthesis.”
Synthesis of HP-β-CD/Pluronic polyrotaxanes with cholesterol 
end-caps. The Pluronic triblock copolymer starting material is 
modi ed so that cholesterol end-caps can be used to keep the 
HP-β-CD molecules (blue structure) threaded. It was found that 
stirring the Pluronic F127 and HP-β-CD for 48 hours a orded 
the best threading e  ciency, while highly threaded HPβ-CD/
L81 polyrotaxanes were obtained after just 1 hour of stirring.
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